Session Tracks

This session will explore the latest diagnostic techniques and biomarkers for liver diseases. Emphasis will be placed on improving early detection and patient outcomes.

This track will focus on novel therapeutic approaches and drug developments targeting various liver diseases. Discussions will include pharmacological advancements and their clinical implications.

This session will examine the role of physiotherapy in managing liver disease patients. Evidence-based practices and rehabilitation strategies will be highlighted.

This track will address the relationship between infectious diseases and liver health. Topics will include viral hepatitis, co-infections, and their management.

This session will delve into the importance of nutrition in the prevention and management of liver diseases. Participants will discuss dietary interventions and their clinical relevance.

This track will present cutting-edge research findings in the field of hepatology. Researchers will share insights into ongoing studies and future directions.

This session will focus on the importance of a patient-centered approach in managing liver diseases. Strategies for enhancing patient engagement and compliance will be discussed.

This track will explore public health initiatives aimed at preventing liver diseases globally. Discussions will include awareness campaigns and policy implications.

This session will investigate the psychosocial challenges faced by patients with liver diseases. The impact of mental health on treatment adherence and quality of life will be examined.

This track will highlight the role of technology in the diagnosis and treatment of liver diseases. Innovations such as telemedicine and digital health tools will be discussed.

This session will provide insights into liver disease research from a global perspective. Researchers will share their findings and discuss collaborative opportunities across borders.